Proactive One2One Virtual Event - Algernon Pharmaceuticals

132 Aufrufe
Published
Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) CEO Christopher J. Moreau presents to investors at Proactive One2One Virtual Event.

The drug re-purposing company investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets.
Kategorien
Corona Virus aktuelle Videos
Kommentare deaktiviert.